Metastatic/Locally Pancreatic Ductal Adenocarcinoma Clinical Trials in Saint-Herblain

Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/Resistance